PocketEdge
← All news

Desk note · industry · FMCG / wellness

Marico lifted its Cosmix Wellness stake to 80% with another ₹1.14 billion purchase

Marico Ltd told exchanges on 6 November 2026 it bought a further 20% of Cosmix Wellness Private Limited for ₹114 crore, taking its holding from 60% to 80% as it doubles down on the premium ayurvedic-and-supplements brand folded into its health foods push.

6 Nov 2026 · 2 min read

Key takeaways

  • •The incremental acquisition values the additional 20% equity at ₹114 crore and lifts Marico’s aggregate stake in Cosmix Wellness to four-fifths.
  • •Cosmix operates in ayurvedic mixes and nutraceutical-style powders sold largely through modern trade and online channels, overlapping Marico’s Saffola portfolio.
  • •Marico has been building a health-foods platform through Parachute Advansed and Saffola extensions; larger control simplifies supply chain and brand capex decisions.

What's going on here?

Indian packaged food giants are buying stakes in digital-native wellness labels because standalone powders and functional drinks ramp faster on marketplaces than legacy atta brands do. Marico’s filing on 6 November said it acquired another fifth of Cosmix Wellness after already owning 60%, paying ₹114 crore for the slice. Consolidated control at 80% lets Marico fold ingredient sourcing, manufacturing, and influencer marketing into its existing health vertical without minority veto points. The transaction is small versus Marico’s total balance sheet but signals strategic priority, not a one-off venture bet.

What does this mean?

Higher ownership converts Cosmix from a partnership into something closer to a division, which usually brings shared logistics with Marico’s wider foods network and stricter margin targets. Competitors from Hindustan Unilever’s health snacks push to ITC’s nutraceutical experiments face the same playbook: acquire capability early before valuations rise with proof of repeat purchase. Premium powders also ride different GST and label rules than edible oil, so one owner reduces compliance fragmentation.

Why should I care?

If you buy Saffola or Cosmix packs online, expect bundled promos and shared distribution sooner rather than later, though Marico will still need to keep the boutique story credible for wellness shoppers. Founders scouting exits should note the valuation implied by the incremental cheque when negotiating with strategics. Investors should watch Marico’s next health-foods revenue disclosure to see whether growth accelerates enough to justify more capital. Track integration costs, goodwill, and any follow-on infusion to scale Cosmix manufacturing.

More desk notes

Disclaimer

For informational purposes only. Not investment advice. Verify with filings and a licensed adviser.